期刊文献+

复方三黄洗液治疗婴幼儿湿疹临床研究 被引量:7

The Clinical Research of Fufang Sanhuang Lotion for Infant Eczema
下载PDF
导出
摘要 目的:观察复方三黄洗液对婴幼儿湿疹的临床疗效,并探讨其作用机理。方法:将50例婴幼儿湿疹患者随机分为治疗组(30例)和对照组(20例),观察两组治疗前后的皮损、症状变化,血液嗜酸性粒细胞(EOS)及IgE值。结果:治疗组临床有效率为93.33%,对照组为65.00%,两组治疗后复发率、IgE、嗜酸性粒细胞比较,均有显著性差异(P<0.05)。结论:复方三黄洗液可以提高婴幼儿湿疹的临床疗效,缩短其疗程,其机理可能与降低患者血液嗜酸性粒细胞及IgE水平有关。 Objective:To observe the clinical efficacy of Fufang sanhuang lotion for infant eczema and detect the functional mechanism.Methods:Put 50 infant eczema cases into two groups,one is experimental group(30 cases) and another one is contract group(20 cases),and then observe the change of skin injury,symptoms,EOS and IgE before and after treatmentResults:The clinical effective rate of experiment group is 93.33%,compared with the clinical effective rate of contract group(65.00%),it has obvious affection.And the reoccurrence rate,level of IgE and EOS of two groups after receiving treatment have distinguished difference(P〈0.05).Conclusion:Fufang sanhuang lotion can improve the clinical efficacy of infant eczema and shorten the treatment course,the possible mechanism may be related with the function of decreasing the level of EOS and IgE.
作者 邹国明 谢斌
机构地区 江西中医学院
出处 《辽宁中医杂志》 CAS 北大核心 2011年第2期297-299,共3页 Liaoning Journal of Traditional Chinese Medicine
关键词 复方三黄洗液 婴幼儿湿疹 机理 Fufang sanhuang lotion infant eczema mechanism
  • 相关文献

参考文献3

二级参考文献14

  • 1Milgrom H, Fick RB, Su JQ, et al. Treatment of allergic asthma with monoclonal anti-IgE antibody[J].N Engl J Med,1999,341(26):1966-1973. 被引量:1
  • 2Prussin C, Griffith DT, Boesel KM, et al. Omalizumab treatment downregulates dendritic cell FcepsilonRI expression [ J ]. J Allergy Clin Immunol, 2003, 112(6):1147-1154. 被引量:1
  • 3Lin H, Boesel KM, Griffith DT, et al. Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils[J].J Allergy Clin Immunol,2004,113(2) :297-302. 被引量:1
  • 4Fahy JV, Fleming HE, Wong HH, et al. The effect of an anti-IgE monoclonal antibody on the early- and lae-phase responses to allergen inhalation in asthmatic subjects[J]. Am J Respir Crit Care Med, 1997,155(6): 1828-1834. 被引量:1
  • 5Boulet LP, Chapman KR, Cote J, et al. Inhibitory effects of an anti-IgE antibody on allergen-induced early asthmatic response[J]. Am J Respir Crit Care Med, 1997,155(6): 1835-1840. 被引量:1
  • 6Busse W, Corren J, Lanier BQ, et al. Omalizumab, an anti-IgE recombination humanized monoclonal antibody, for the treatment of severe allergic asthma [J] .J Allergy Clin Immunol,2001,108(2): 184-190. 被引量:1
  • 7Soler M,Matz J,Townley R, et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics[J]. Eur Respir J,2001,18(2) :254-261. 被引量:1
  • 8Buhl R, Soler M, Matz J, et al. The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma[J]. Eur Respir J,2002,20(5): 1088-1094. 被引量:1
  • 9Finn A, Gross G, van Bavel J, et al. Omalizumab improves asthma-related quality of life in patients with severe allergic asthma [ J ]. J Allergy Clin Immunol,2003,111(2): 278-284. 被引量:1
  • 10Aderoth E, Rak S, Haahtela T, et al. Recombinant humanized mAb-E25, an anti-IgE mAb in birch pollen-induced seasonal allergic rhinitis[J]. J Allergy Clin Immunol,2000, 106(2) :253-259. 被引量:1

共引文献12

同被引文献133

引证文献7

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部